dermatologist looks at hands of patientGene targeting drug therapy may offer hope for those with difficult-to-treat advanced-stage skin cancer according to preliminary data published last week in the New England Journal of Medicine.  

Treatment with the drug was able to shrink tumors and slow the progression of the disease for 81 percent of patients with metastatic melanoma. 

“This type of treatment gets to the root of what caused the cancer,” says lead author Dr. Keith Flaherty, and provides hope for patients who until now had few, if any effective treatment options.

WATCH the video below, or read the story at ABC News


Leave a Reply